Immunohistochemical studies found that GAP-43 levels were decreased in the neocortex but was preserved or even elevated in the hippocampus of AD patients (Masliah et al., 1991; De La Monte et al., 1995; Bogdanovic et al., 2000; Rekart et al., 2004). The gene discussed is GAP43; the disease is Alzheimer disease.